SELLAS Life Sciences Group, Inc. (FRA:RXK3)
3.210
-0.155 (-4.61%)
Last updated: Jan 9, 2026, 10:32 AM CET
241.49% (1Y)
| Market Cap | 423.70M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -22.11M |
| Shares Out | n/a |
| EPS (ttm) | -0.24 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 4,852 |
| Open | 3.135 |
| Previous Close | 3.365 |
| Day's Range | 3.135 - 3.210 |
| 52-Week Range | 0.877 - 4.495 |
| Beta | n/a |
| RSI | 63.14 |
| Earnings Date | Mar 18, 2026 |